'Momentous occasion': UCL experts greet first drug approved for early Alzheimer鈥檚 disease in the UK
22 August 2024
Lecanemab has been approved for use in the UK following decades of work supported by UCL academics. The news was welcomed by Professor Sir John Hardy, Professor Jonathan Schott, Dr Cath Mummery (UCL Queen Square Institute of Neurology) & Professor Robert Howard (UCL Psychiatry).
Close
